(R)-(+)-THALIDOMIDE
Title | Journal |
---|---|
Targeting the tumor microenvironment: focus on angiogenesis. | Journal of oncology 20120101 |
[The Neurosedyn disaster became a starting shot. The drug approval process was changed and new era of patient safety was initiated]. | Lakartidningen 20111101 |
Isomin: a novel cytoplasmic intermediate filament protein from an arthropod species. | BMC biology 20110101 |
History and phylogeny of intermediate filaments: now in insects. | BMC biology 20110101 |
Epidemiological surveillance of birth defects compatible with thalidomide embryopathy in Brazil. | PloS one 20110101 |
Radiotherapy and 'new' drugs-new side effects? | Radiation oncology (London, England) 20110101 |
Evaluating the efficacy of tryptophan fluorescence and absorbance as a selection tool for identifying protein crystals. | Acta crystallographica. Section F, Structural biology and crystallization communications 20100301 |
Angiogenesis inhibition in prostate cancer: current uses and future promises. | Journal of oncology 20100101 |
The legal standards for the radioactive or non radioactive drugs research and approval in the European Community and in Germany after the thalidomide catastrophe. | Hellenic journal of nuclear medicine 20100101 |
Anti-angiogenesis therapies: their potential in cancer management. | OncoTargets and therapy 20100101 |
Progranulin modulates zebrafish motoneuron development in vivo and rescues truncation defects associated with knockdown of Survival motor neuron 1. | Molecular neurodegeneration 20100101 |
Synthesis, configurational stability and stereochemical biological evaluations of (S)- and (R)-5-hydroxythalidomides. | Bioorganic & medicinal chemistry letters 20090715 |
Comparison between measurements obtained with three different perineometers. | Clinics (Sao Paulo, Brazil) 20090601 |
Effects of inducible nitric oxide synthase inhibition or norepinephrine on the neurovascular coupling in an endotoxic rat shock model. | Critical care (London, England) 20090101 |
Progranulin is expressed within motor neurons and promotes neuronal cell survival. | BMC neuroscience 20090101 |
[Contergan writes its history (interview by Angelika Staub)]. | Kinderkrankenschwester : Organ der Sektion Kinderkrankenpflege 20071201 |
Evaluation of chemical and photochemical oxidation processes for degradation of phosmet on lowbush blueberries (Vaccinium angustifolium). | Journal of agricultural and food chemistry 20061213 |
Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods. | Journal of molecular graphics & modelling 20061101 |
Organophosphate pesticide exposure and neurobehavioral performance in agricultural and non-agricultural Hispanic workers. | Environmental health perspectives 20060501 |
Comparative effectiveness of different insecticides for organic management of blueberry maggot (Diptera: Tephritidae). | Journal of economic entomology 20050801 |
Variation in organophosphate pesticide metabolites in urine of children living in agricultural communities. | Environmental health perspectives 20050401 |
Teratology in cultural documents and today. | Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft 20041201 |
Mechanisms of action and potential therapeutic uses of thalidomide. | Croatian medical journal 20020601 |
[On the history of the Contergan (thalidomide) catastrophe in the light of drug legislation]. | Deutsche medizinische Wochenschrift (1946) 20011019 |
Structure-activity relationships for a large diverse set of natural, synthetic, and environmental estrogens. | Chemical research in toxicology 20010301 |
Thalomid (Thalidomide) capsules: a review of the first 18 months of spontaneous postmarketing adverse event surveillance, including off-label prescribing. | Drug safety 20010101 |
Thalidomide as an anti-angiogenic agent in relapsed gliomas. | Journal of neuro-oncology 20010101 |